
IscB (insertion sequences Cas9‑like OrfB)
$2,400.00 - $4,800.00
All products have special prices for bulk purchase, please contact for more details if required.
Cat. No.: ISCB-500 (for 500pmol)
Cat. No.: ISCB-2500 (for 2500pmol)
Description
IscB (insertion sequences Cas9‑like OrfB) is an RNA‑guided DNA nuclease encoded within the IS200/IS605 transposon family and is considered an evolutionary ancestor of the CRISPR‑Cas9 system. As a member of the OMEGA (Obligate Mobile Element‑Guided Activity) system family, its discovery provides key insights into the molecular evolution of CRISPR‑Cas systems.
IscB is composed of only ~400 amino acids—substantially smaller than canonical Cas9 proteins (1,000–1,400 aa). This compact size results primarily from the absence of the α‑helical recognition lobe (REC lobe) that mediates target recognition in Cas9. Despite its reduced size, IscB retains the core nuclease domains found in Cas9, including the RuvC and HNH domains, which cleave the two strands of target DNA. In addition, IscB contains an N‑terminal PLMP domain and a C‑terminal TAM‑interaction domain (TID).
IscB functions as a ribonucleoprotein complex with its cognate ωRNA, a 200–400 nt non‑coding RNA that is significantly larger than the crRNA:tracrRNA duplex used by Cas9. Cryo‑EM structural studies reveal that the extensive ωRNA scaffold compensates for the missing REC lobe by participating directly in the recognition of the RNA–DNA heteroduplex. This unique structural adaptation represents one of the most distinctive evolutionary innovations of the IscB system.
- Development of Ultra‑Compact Gene Editors: Serving as a foundational scaffold for engineering next‑generation, highly compact genome‑editing tools.
- Evolutionary Studies: Enabling investigation into the evolutionary origins and diversification of CRISPR systems.
- Novel Delivery Strategies: Its small protein size makes it highly compatible with diverse delivery platforms, including those with strict cargo‑size limitations.
- Mechanistic Research: Facilitating structural and functional studies of RNA‑guided nucleases and their RNA–DNA recognition mechanisms.
- Biotechnology Tool Development: Providing a versatile framework for protein engineering aimed at improving editing efficiency, specificity, or programmability.
SBS Genetech is recognized as one of the global major leading industry players in Gene Editing by third-party market researchers. For more details, please visit Global Gene Editing Service Market 2019 by Company, Regions, Type and Application, Forecast to 2024.
Related:
- Synthetic sgRNAs
- Cas12a Nuclease (Lyophilized)
- Cas12b Nuclease (Lyophilized)
- Cas13a Nuclease (Lyophilized)
- Cas14a1 Nuclease (Lyophilized)
- SpCas9 Nuclease (Lyophilized)
- SuCas12a2 Nuclease (Lyophilized)
- dCas9 NLS (Lyophilized)
- EiCsm6 (Lyophilized)
- LwaCas13a Nuclease (Lyophilized)
- BrCas12a Nuclease (Lyophilized)
- AsCas12a Nuclease (Lyophilized)
- Cas9 Nuclease (with NLS)
- Cas9 HF-NLS (SpCas9 HF-NLS)
- CRISPR-dCas9 Nuclease
- dCas9 NLS
- spCas9
- SpdCas9
- spCas9-NG
- SpRYCas9
- Cas9 Nickase (H840A) NLS
- Cas9 Nickase (D10A) NLS
- TsCas12a
- OsCas12a
- HkCas12a
- BoCas12a
- AsCas12a
- FnCas12a
- LbCas12a (Cpf1) Nuclease
- Enhanced LbaCas12a (Cpf1)
- Lb5Cas12a (Cpf1) Nuclease
- SuCas12a2 Nuclease
- AaCas12b
- AacCas12b
- AapCas12b
- BrCas12b
- LwCas13a
- LbuCas13a
- LtrCas13a (C2c2) Nuclease
- LwaCas13a (C2c2) Nuclease
- EiCsm6
- HheCas13a (C2c2)
- TccCas13a (C2c2)
- YmeCas12a (Cpf1)
- CmeCas12a (Cpf1)
- Enhanced LbCas12a
- PfAgo
- TtAgo
- T7 Endonuclease I










